📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Forty Seven

1.1 - Company Overview

Forty Seven Logo

Forty Seven

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage immuno-oncology therapies targeting cancer immune evasion pathways, based on technology licensed from Stanford University. Lead program 5F9 is a monoclonal antibody against the CD47 receptor, a 'don't eat me' signal that cancer cells commandeer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Forty Seven

Gradalis Logo

Gradalis

HQ: United States Website
  • Description: Provider of personalized cancer immunotherapy leveraging patients' own genetically modified tumor cells to enhance immune recognition and killing through its Vigil platform, and of clinical trials evaluating the safety and efficacy of Vigil across cancer types, including ovarian cancer and Ewing’s sarcoma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gradalis company profile →
Elevation Oncology Logo

Elevation Oncology

HQ: United States Website
  • Description: Provider of precision medicines as a clinical-stage biopharmaceutical company, developing EO-3021, an antibody-drug conjugate targeting Claudin 18.2 for advanced/metastatic solid tumors, particularly gastric and gastroesophageal junction adenocarcinoma, and Seribantumab, an anti-HER3 monoclonal antibody for NRG1 fusion-positive tumors; conducts clinical trials and offers compassionate use.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elevation Oncology company profile →
Exact Sciences Logo

Exact Sciences

HQ: United States Website
  • Description: Provider of cancer diagnostics, including Cologuard, a non-invasive at-home stool-based colorectal cancer screening test for individuals 45+, Riskguard hereditary cancer testing, Oncotype DX Breast Recurrence Score to assess recurrence and guide treatment for ER+/HER2- breast cancer, OncoExTra genomic profiling for therapy selection in advanced/metastatic cancer, and under-development Breast Radiation Score and colorectal cancer blood test.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exact Sciences company profile →
Attovia Therapeutics Logo

Attovia Therapeutics

HQ: United States Website
  • Description: Provider of a biologics platform and pipeline of biotherapeutics for immune-mediated diseases, featuring ATTOBODY to generate binders and biparatopic biologics as alternatives to IgG-based medicines; programs include ATTO-1310 (IL31), ATTO-002 (IL31 x IL13), ATTO-004 (novel GPCR), and ATTO-005 (IBD).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Attovia Therapeutics company profile →
Theranostics Health Logo

Theranostics Health

HQ: United States Website
  • Description: Provider of proteomics-based diagnostics and research services for drug development companies, developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor, utilizing Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theranostics Health company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Forty Seven

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Forty Seven

2.2 - Growth funds investing in similar companies to Forty Seven

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Forty Seven

4.2 - Public trading comparable groups for Forty Seven

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Forty Seven

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Forty Seven

What does Forty Seven do?

Forty Seven is a provider of clinical-stage immuno-oncology therapies targeting cancer immune evasion pathways, based on technology licensed from Stanford University. Lead program 5F9 is a monoclonal antibody against the CD47 receptor, a 'don't eat me' signal that cancer cells commandeer.

Who are Forty Seven's competitors?

Forty Seven's competitors and similar companies include Gradalis, Elevation Oncology, Exact Sciences, Attovia Therapeutics, and Theranostics Health.

Where is Forty Seven headquartered?

Forty Seven is headquartered in United States.

How many employees does Forty Seven have?

Forty Seven has 1,000 employees 🔒.

When was Forty Seven founded?

Forty Seven was founded in 2010 🔒.

What sector and industry vertical is Forty Seven in?

Forty Seven is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Forty Seven

Who are the top strategic acquirers in Forty Seven's sector and industry

Top strategic M&A buyers and acquirers in Forty Seven's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Forty Seven?

Top strategic M&A buyers groups and sectors for Forty Seven include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Forty Seven's sector and industry vertical

Which are the top PE firms investing in Forty Seven's sector and industry vertical?

Top PE firms investing in Forty Seven's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Forty Seven's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Forty Seven's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Forty Seven's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Forty Seven include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Forty Seven's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Forty Seven?

The key public trading comparables and valuation benchmarks for Forty Seven include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Forty Seven for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Forty Seven with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Forty Seven's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Forty Seven with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Forty Seven's' sector and industry vertical?

Access recent funding rounds and capital raises in Forty Seven's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Forty Seven

Launch login modal Launch register modal